GRIN1 and depressive symptom measurement: Acubin inhibits glutamate receptor NMDAR1 and oxidative stress, thereby improving Glu excitotoxicity, and improving PC-12 cell damage induced by Glu, which has potential activity in the treatment of depression (Lu et al., 2022).